Cormorant (private company)
See something wrong or missing? Let us know
Offices:Stockholm
Industry:Biotech
Business model:B2B
Based at the Karolinska Institute Science Park in Stockholm (Sweden), Cormorant was a private Biotech focusing on cancer immunotherapies.
Its main program was HuMax-IL8, which is currently in Phase I/II trials. This therapeutic antibody targets interleukin-8 (IL-8), a protein is expressed by many solid tumors. IL-8 also suppresses the immune system and increases the ability of tumors to metastasize.
values in USD
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Cormorant
| Name | Criteria | |
|---|---|---|
 |
AbolerIS Pharma
23%
|
|
 |
Abzena
23%
|
|
 |
Accure Therapeutics
23%
|
|
 |
Acesion Pharma
23%
|
|
|
Achilles Therapeutics
23%
|
|
 |
Adrenomed AG
23%
|
|
|
AFYX Therapeutics
23%
|
|
 |
Age Labs AS
23%
|
|
|
Agrinos
23%
|
|
|
Algenex
23%
|
|
Belgium
Netherlands
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Ireland
Italy
Portugal